{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:20:40Z","timestamp":1783498840411,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.neuropharm.2023.109801","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T18:21:52Z","timestamp":1701282112000},"page":"109801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Serotonergic agonism and pharmacologically-induced adolescent stress cause operant-based learning deficits in mice"],"prefix":"10.1016","volume":"244","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2222-9714","authenticated-orcid":false,"given":"Carey","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-3971","authenticated-orcid":false,"given":"Thibault","family":"Renoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109801_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2470547018758043","article-title":"The role of stress in the pathogenesis and maintenance of obsessive-compulsive disorder","volume":"2","author":"Adams","year":"2018","journal-title":"Chronic Stress"},{"key":"10.1016\/j.neuropharm.2023.109801_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuroscience.2011.08.070","article-title":"Current animal models of obsessive compulsive disorder: an update","volume":"211","author":"Albelda","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2023.109801_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fnbeh.2017.00237","article-title":"Adolescent corticosterone and TrkB pharmaco-manipulations sex-dependently impact instrumental reversal learning later in life","volume":"11","author":"Barfield","year":"2017","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109801_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fnmol.2014.00024","article-title":"Early-life stress induces persistent alterations in 5-HT1A receptor and serotonin transporter mRNA expression in the adult rat brain","volume":"7","author":"Bravo","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"12","key":"10.1016\/j.neuropharm.2023.109801_bib5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/NMD.0000000000000049","article-title":"The role of early life stress in adult psychiatric disorders: a systematic review according to childhood trauma subtypes","volume":"201","author":"Carr","year":"2013","journal-title":"J. Nerv. Ment. Dis."},{"issue":"11","key":"10.1016\/j.neuropharm.2023.109801_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007745","article-title":"Pharmacological alterations of anxious behaviour in mice depending on both strain and the behavioural situation","volume":"4","author":"Clement","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109801_bib7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/BF00207243","article-title":"Effects in the X-maze anxiety model of agents acting at 5-HT 1 and 5-HT 2 receptors","volume":"93","author":"Critchley","year":"1987","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109801_bib8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuron.2009.04.017","article-title":"Neurogenesis-dependent and-independent effects of fluoxetine in an animal model of anxiety\/depression","volume":"62","author":"David","year":"2009","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109801_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1749-6632.1998.tb10176.x","article-title":"5\u2010HT1B receptor modulation of prepulse inhibition: recent findings in wild\u2010type and 5\u2010HT1B knockout mice","volume":"861","author":"Dulawa","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109801_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(80)90117-X","article-title":"Biochemical assessment of the central 5-HT agonist activity of RU 24969 (a piperidinyl indole)","volume":"63","author":"Euvrard","year":"1980","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109801_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s002130050773","article-title":"The pharmacology of impulsive behaviour in rats IV: the effects of selective serotonergic agents on a paced fixed consecutive number schedule","volume":"140","author":"Evenden","year":"1998","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109801_bib12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0028-3908(91)90082-M","article-title":"Tolerance to the behavioural effect of serotonergic (5-HT1B) agonists in the isolationinduced social behavioural deficit test","volume":"30","author":"Frances","year":"1991","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109801_bib13","first-page":"31","article-title":"Effects of RU 24969 on serotonin release in rat brain cortex: further support for the identity of serotonin autoreceptors with 5-HT1B sites","volume":"288","author":"G\u00f6thert","year":"1987","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"10","key":"10.1016\/j.neuropharm.2023.109801_bib14","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.biopsych.2008.06.016","article-title":"Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone","volume":"64","author":"Gourley","year":"2008","journal-title":"Biol. Psychiatr."},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109801_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.biopsych.2007.07.016","article-title":"Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression","volume":"63","author":"Gourley","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109801_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fnbeh.2018.00227","article-title":"Sex-dependent effects of environmental enrichment on spatial memory and brain-derived neurotrophic factor (BDNF) signaling in a developmental \"Two-Hit\" mouse model combining BDNF haploinsufficiency and chronic glucocorticoid stimulation","volume":"12","author":"Grech","year":"2018","journal-title":"Front. Behav. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109801_bib17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0028-3908(84)90147-3","article-title":"The behavioural effects of RU 24969, a suggested 5-HT1 receptor agonist in rodents and the effect on the behaviour of treatment with antidepressants","volume":"23","author":"Green","year":"1984","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2023.109801_bib18","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1017\/S0033291711000894","article-title":"Risk factors prospectively associated with adult obsessive\u2013compulsive symptom dimensions and obsessive\u2013compulsive disorder","volume":"41","author":"Grisham","year":"2011","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109801_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000079970","article-title":"Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan","volume":"50","author":"Gross-Isseroff","year":"2004","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109801_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00213-015-4086-8","article-title":"Clinically effective OCD treatment prevents 5-HT1B receptor-induced repetitive behavior and striatal activation","volume":"233","author":"Ho","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.neuropharm.2023.109801_bib21","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1152\/jn.00143.2005","article-title":"Corticosterone slowly enhances miniature excitatory postsynaptic current amplitude in mice CA1 hippocampal cells","volume":"94","author":"Karst","year":"2005","journal-title":"J. Neurophysiol."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2023.109801_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0149-7634(03)00006-X","article-title":"Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence","volume":"27","author":"Laviola","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109801_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00737-015-0526-z","article-title":"Is serotonin transporter polymorphism (5-HTTLPR) allele status a predictor for obsessive-compulsive disorder? A meta-analysis","volume":"18","author":"Mak","year":"2015","journal-title":"Arch. Wom. Ment. Health"},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109801_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/026988110201600310","article-title":"Corticosterone modulation of somatodendritic 5-HT1A receptor function in mice","volume":"16","author":"Man","year":"2002","journal-title":"J. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109801_bib25","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41386-018-0307-2","article-title":"Impaired instrumental reversal learning is associated with increased medial prefrontal cortex activity in Sapap3 knockout mouse model of compulsive behavior","volume":"44","author":"Manning","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109801_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112982","article-title":"Effects of repeated RU 24969 treatment on the locomotor activity, motoric capacity, and axillary temperatures of male and female preweanling rats","volume":"398","author":"McDougall","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109801_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172857","article-title":"Serotonin 5-HT1A and 5-HT1B receptors co-mediate the RU 24969-induced locomotor activity of male and female preweanling rats","volume":"189","author":"McDougall","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109801_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/ijnp\/pyab060","article-title":"Brain 5-HT1A receptor PET binding, cortisol responses to stress, and the familial transmission of suicidal behavior","volume":"25","author":"Melhem","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109801_bib29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0163-1047(81)91162-6","article-title":"Intraventricular corticosterone injection facilitates memory of an appetitive discriminative task in mice","volume":"31","author":"Micheau","year":"1981","journal-title":"Behav. Neural. Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109801_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-2999(84)90675-7","article-title":"Time-dependent effects of posttraining intrahippocampal injections of corticosterone on retention of appetitive learning tasks in mice","volume":"106","author":"Micheau","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109801_bib31","series-title":"The Medical Basis of Psychiatry","first-page":"169","article-title":"Obsessive compulsive disorder","author":"Murphy","year":"2016"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109801_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41398-018-0210-y","article-title":"Adiporon, an adiponectin receptor agonist acts as an antidepressant and metabolic regulator in a mouse model of depression","volume":"8","author":"Nicolas","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109801_bib33","article-title":"Interaction of reelin and stress on immobility in the forced swim test but not dopamine-mediated locomotor hyperactivity or prepulse inhibition disruption: relevance to psychotic and mood disorders","author":"Notaras","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2023.109801_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.113865","article-title":"Acute serotonin 1B\/1A receptor activation impairs behavioral flexibility in C57BL\/6J mice","volume":"427","author":"Oliver","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109801_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bbr.2012.10.032","article-title":"Effects of chronic low-and high-dose nicotine on cognitive flexibility in C57BL\/6J mice","volume":"238","author":"Ortega","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109801_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02245695","article-title":"Quantitative assessment of the microstructure of rat behavior: if (d), the extension of the scaling hypothesis","volume":"113","author":"Paulus","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109801_bib37","first-page":"323","article-title":"Animal models of OCD: a conceptual framework","author":"Pittenger","year":"2017","journal-title":"Obsessive-Compulsive Disorder: Phenomenology, Pathophysiology, and Treatment"},{"key":"10.1016\/j.neuropharm.2023.109801_bib38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bbr.2017.06.009","article-title":"Environmental enrichment reduces innate anxiety with no effect on depression-like behaviour in mice lacking the serotonin transporter","volume":"332","author":"Rogers","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109801_bib39","doi-asserted-by":"crossref","first-page":"e794","DOI":"10.1038\/tp.2016.52","article-title":"Dissociating the therapeutic effects of environmental enrichment and exercise in a mouse model of anxiety with cognitive impairment","volume":"6","author":"Rogers","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109801_bib40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbr.2015.03.063","article-title":"Gene\u2013environment interaction of reelin and stress in cognitive behaviours in mice: implications for schizophrenia","volume":"287","author":"Schroeder","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109801_bib41","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1038\/s41598-020-59646-4","article-title":"Transdiagnostic phenotyping reveals a host of metacognitive deficits implicated in compulsivity","volume":"10","author":"Seow","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.neuropharm.2023.109801_bib42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.biopsych.2008.09.026","article-title":"Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice","volume":"65","author":"Shanahan","year":"2009","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109801_bib43","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.mcn.2017.10.007","article-title":"Corticosteroid-induced dendrite loss and behavioral deficiencies can be blocked by activation of Abl2\/Arg kinase","volume":"85","author":"Shapiro","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109801_bib44","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neubiorev.2017.05.029","article-title":"A review of the role of serotonin system genes in obsessive-compulsive disorder","volume":"80","author":"Sinopoli","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109801_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/2167702614534210","article-title":"Obsessive-compulsive disorder is associated with broad impairments in executive function: a meta-analysis","volume":"3","author":"Snyder","year":"2015","journal-title":"Clin. Psychol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109801_bib46","article-title":"Selective serotonin re\u2010uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)","volume":"1","author":"Soomro","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.neuropharm.2023.109801_bib47","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cpr.2011.06.007","article-title":"Early versus late onset obsessive-compulsive disorder: evidence for distinct subtypes","volume":"31","author":"Taylor","year":"2011","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.neuropharm.2023.109801_bib48","series-title":"Obsessive-Compulsive Disorder: Phenomenology, Pathophysiology, and Treatment","first-page":"385","article-title":"Pharmacological and behavioral rodent models of OCD","author":"Thompson","year":"2017"},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109801_bib49","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00213-019-05397-8","article-title":"Ketamine induces immediate and delayed alterations of OCD-like behavior","volume":"237","author":"Thompson","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109801_bib50","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.conb.2011.04.010","article-title":"Neurobiology of obsessive\u2013compulsive disorder: insights into neural circuitry dysfunction through mouse genetics","volume":"21","author":"Ting","year":"2011","journal-title":"Curr. Opin. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109801_bib51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0091-3057(00)00232-X","article-title":"Effect of 5-HT1B receptor ligands on self-administration of ethanol in an operant procedure in rats","volume":"66","author":"Tomkins","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109801_bib52","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0028-3908(86)90014-6","article-title":"Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist, RU 24969, in the rat","volume":"25","author":"Tricklebank","year":"1986","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109801_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12557","article-title":"Behavioral flexibility in a mouse model for obsessive\u2010compulsive disorder: impaired Pavlovian reversal learning in SAPAP3 mutants","volume":"18","author":"van den Boom","year":"2019","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2023.109801_bib54","article-title":"Mechanisms of pathogenesis and environmental moderators in preclinical models of compulsive-like behaviours","volume":"106223","author":"Wilson","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2023.109801_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107998","article-title":"Antidepressant-like effects of ketamine in a mouse model of serotonergic dysfunction","author":"Wilson","year":"2020","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109801_bib56","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00213-013-2985-0","article-title":"Effects of chronic fluoxetine treatment on serotonin 1B receptor-induced deficits in delayed alternation","volume":"227","author":"Woehrle","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2023.109801_bib57","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jad.2010.11.005","article-title":"Chronic corticosterone administration from adolescence through early adulthood attenuates depression-like behaviors in mice","volume":"131","author":"Xu","year":"2011","journal-title":"J. Affect. Disord."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082300391X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082300391X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:26:51Z","timestamp":1758439611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082300391X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":57,"alternative-id":["S002839082300391X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109801","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotonergic agonism and pharmacologically-induced adolescent stress cause operant-based learning deficits in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109801"}}